Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 224-207-2 | CAS number: 4246-51-9
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Link to relevant study record(s)
Description of key information
No experimental data on absorption, metabolism and distribution are available for the substance. Therefore, the toxicokinetic behavior was evaluated based on the structure and the physico-chemical properties of the substance as well as data from experimental in vivo toxicity studies.
The test substance belongs as low molecular weight polyetherdiamine to the structural class of etherdiamines.
Absorption is expected for the oral, dermal and inhalation route. Since the test substance is excellent miscible in water, a distribution through extracellular body fluids is likely. Moreover, the corrosive properties of the test substance might increase absorption. Metabolism might occur, e.g. via N-acetylation. Excretion will most likely occur via the urine. No bioaccumulation is expected.
Key value for chemical safety assessment
- Bioaccumulation potential:
- no bioaccumulation potential
- Absorption rate - oral (%):
- 100
- Absorption rate - dermal (%):
- 100
- Absorption rate - inhalation (%):
- 100
Additional information
The main toxicokinetic properties of the polyetherdiamine 3,3'-oxybis(ethyleneoxy)bis(propylamine) (EC-No. 224-207-2) are assessed on the basis of its physico-chemical properties and with special regard to the results of the standard toxicity studies performed with this substance. Substance specific toxicokinetic or dermal absorption studies are not available.
1. Relevant physico-chemical properties of 3,3'-oxybis(ethyleneoxy)bis(propylamine
Molecular weight: 220.3 g/mol
Physical state: liquid at room temperature
Boiling point: not applicable (decomposes before boiling)
logPow: -1.25 (at 25 °C, pH 11.1)
Water solubility: miscible with water in any ratio
pKa: 10.0 (at 20 °C)
Vapour pressure: 0.00005 hPa at 20 °C
Hydrolysis: Hydrolysis is not expected due to the absence of hydrolysable groups.
Surface tension: Based on chemical structure, no surface activity is predicted.
2. Absorption:
Oral absorption
The molecular weight of the substance (below 500) favours absorption after oral exposure. In contrast, the following factors are more in favour of a limited oral absorption: It is generally thought that ionised substances do not readily pass biological membranes. As the pKa is 10, most of the substance will be ionized at the pH range present in the gastro-intestinal tract. The very high water solubility and the log Pow below -1 indicate that passive diffusion through membranes might be limited by the rate at which the substance partitions out of the gastrointestinal fluid. Furthermore, the molecular weight of > 200 g/mol might restrict passage through the aqueous pores or transport through the epithelial barrier by the bulk passage of water.
Following single or repeated oral gavage administration, the substance causes corrosive and/or irritating effects in stomach and intestine. Thus, it is possible that oral absorption is enhanced due to damage to cell membranes. It is therefore concluded that a higher oral aborption can be assumed following administration of irritant/corrosive substance doses whereas a lower oral absorption can be assumed at non-irritating substance doses.
In a repeated dose toxicity study (combined with the reproduction / developmental toxicity test, OECD 422) in rats the substance caused signs of systemic toxicity (decreased food consumption and decreased body weight parameters), revealing that absorption has occurred. However, apart from that, no specific data concerning oral absorption of the test substance are available
Dermal absorption
Dermal absorption of the pure substance can be assumed because of its corrosive properties, which leads to the destruction of the skin barrier (as observed in the acute dermal toxicity study on rat skin as well as in the skin irritation/corrosion study on rabbit skin). In contrast, the dermal absorption at non-irritating substance concentrations can be assumed to be very low. This is due to the fact that at the skin’s slightly acidic pH the substance will be ionised and thus, not be able to penetrate through the intact skin.
Inhalation absorption
The low volatility (vapour pressure of 0.00005 hPa at 20 °C) indicates that a vapour inhalation exposure is unlikely.
If exposure to respirable aerosol occurs, the very high water solubility and log Pow below -1 indicate that the substance may be retained in the mucus of the respiratory tract, thus, limiting inhalation absorption. However, the corrosive properties of the substance could cause a destruction of epithelial membranes, which would lead to an enhanced absorption.
Overall, it is concluded that inhalation absorption at a similar rate to oral absorption can be assumed.
Altogether, due to the lack of data concerning the absorption of the test substance a worst case of 100 % absorption after oral uptake, dermal exposure, and inhalation is assumed.
3. Distribution/Metabolism:
At physiological pH the highly water soluble substance will be mostly ionised. Thus, diffusion across membranes might be limited and distribution throughout the body via the extracellular aqueous compartment seems likely. Distribution to the central nervous system and testis is likely to be restricted by the blood-brain and blood-testis barriers.
The clinical signs observed in toxicity studies are mainly indicative for local irritating/corrosive effects and do not allow a conclusion regarding distribution.
For diamines N-acetylation has been described (e.g. Leung, 2000). Furthermore, the sensitising properties of diamines such as ethylenediamine and 3-dimethylaminopropylamine have been assigned to desamination reactions leading to the respective aldehydes and subsequent reaction with proteins (e.g. Aptula et al., 2005). These metabolic pathways are also likely for the present diamine.
The conversion into a metabolite that was more cytotoxic or more genotoxic than the parent substance was not noted when comparing in vitro test results with metabolic activation to in vitro test results without metobolic activation system (genetic toxicity tests). Based on this, an indication is not given that the formation of cytotoxic metabolites is likely.
4. Excretion:
The relative low molecular weight (below 300 g/mol) and high water solubility of 3,3' oxybis(ethyleneoxy)bis(propylamine) lead to the conclusion that urinary excretion will be the most relevant route of excretion in the rat. Furthermore, the logPow indicates no potential for accumulation in the tissues.
References
Aptula AO, Patlewicz G and Roberts DW (2005). Skin sensitization: Reaction mechanistic applicability domains for structure-activity relationship. Chem. Res. Toxicol. 18: 1420 -1426.
Leung HW (2000). Pharmacokinetics and metabolism of ethylenediamine in the swiss webster mouse following oral or intravenous dosing. Toxicol Lett. 117(1 -2):107 -14.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.